Regeneron Pharmaceuticals, Inc. - Penyata Pendapatan (TTM)

Regeneron Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75886F1075

Penyata Pendapatan (TTM)

Regeneron Pharmaceuticals, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 7,938 8,497 9,198 12,384 13,543 16,072 16,508 14,227 13,710 12,173 12,370 12,671 13,097 13,117 13,100 13,489 13,847 14,202 14,086 14,214
Perubahan (%) 7.05 8.24 34.64 9.36 18.67 2.72 -13.82 -3.63 -11.21 1.62 2.43 3.37 0.15 -0.13 2.97 2.65 2.56 -0.82 0.91
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 3,531 3,767 4,105 4,515 4,675 5,298 5,495 5,179 5,289 5,153 5,463 5,862 6,144 6,255 6,378 6,568 6,819 7,102 7,212 7,484
Perubahan (%) 6.67 8.96 10.00 3.54 13.32 3.73 -5.76 2.13 -2.58 6.02 7.30 4.82 1.80 1.97 2.98 3.82 4.15 1.54 3.77
% daripada Hasil 44.49 44.33 44.63 36.46 34.52 32.96 33.29 36.40 38.58 42.33 44.16 46.26 46.91 47.68 48.69 48.69 49.25 50.01 51.20 52.65
Keuntungan Operasi Kasar 4,406 4,730 5,093 7,869 8,868 10,774 11,013 9,048 8,421 7,020 6,907 6,809 6,953 6,862 6,722 6,921 7,028 7,100 6,874 6,730
Perubahan (%) 7.35 7.67 54.51 12.69 21.50 2.21 -17.84 -6.93 -16.63 -1.61 -1.42 2.11 -1.30 -2.05 2.96 1.55 1.02 -3.18 -2.08
% daripada Hasil 55.51 55.67 55.37 63.54 65.48 67.04 66.71 63.60 61.42 57.67 55.84 53.74 53.09 52.32 51.31 51.31 50.75 49.99 48.80 47.35
SG&A 1,459 1,346 1,384 1,451 1,569 1,825 1,869 1,931 2,015 2,116 2,267 2,443 2,554 2,631 2,719 2,826 2,900 2,954 2,898 2,774
Perubahan (%) -7.75 2.85 4.80 8.14 16.32 2.43 3.30 4.36 5.01 7.14 7.75 4.56 3.02 3.34 3.93 2.62 1.88 -1.90 -4.30
% daripada Hasil 18.38 15.84 15.05 11.71 11.58 11.35 11.32 13.57 14.70 17.38 18.33 19.28 19.50 20.06 20.76 20.95 20.94 20.80 20.58 19.51
R&D
Perubahan (%)
% daripada Hasil
OpEx 4,817 4,832 5,208 5,704 6,069 7,077 7,339 7,098 7,205 7,179 7,660 8,251 8,690 8,884 9,096 9,393 9,719 10,057 10,110 10,258
Perubahan (%) 0.32 7.78 9.52 6.39 16.61 3.71 -3.28 1.51 -0.37 6.70 7.72 5.32 2.23 2.39 3.27 3.46 3.48 0.53 1.45
% daripada Hasil 60.69 56.87 56.63 46.06 44.81 44.03 44.46 49.89 52.55 58.97 61.92 65.12 66.35 67.73 69.43 69.64 70.19 70.81 71.78 72.16
Pendapatan operasi 3,120 3,665 3,989 6,680 7,474 8,995 9,169 7,128 6,505 4,994 4,710 4,420 4,407 4,233 4,004 4,096 4,128 4,145 3,975 3,957
Perubahan (%) 17.44 8.86 67.45 11.89 20.35 1.93 -22.25 -8.75 -23.23 -5.68 -6.17 -0.29 -3.95 -5.41 2.29 0.80 0.40 -4.10 -0.47
% daripada Hasil 39.31 43.13 43.37 53.94 55.19 55.97 55.54 50.11 47.45 41.03 38.08 34.88 33.65 32.27 30.57 30.36 29.81 29.19 28.22 27.84
Perbelanjaan Faedah -49 -57 -65 -70 -58 -57 -56 -55 -56 -59 -64 -70 -72 -73 -71 -67 -63 -55 -48 -37
Perubahan (%) 16.60 14.94 7.19 -17.26 -1.21 -1.75 -2.31 2.00 5.88 7.41 9.09 3.59 1.25 -2.60 -5.77 -5.97 -12.38 -13.41 -23.43
% daripada Hasil -0.61 -0.67 -0.71 -0.57 -0.43 -0.36 -0.34 -0.39 -0.41 -0.49 -0.52 -0.55 -0.55 -0.56 -0.54 -0.50 -0.45 -0.39 -0.34 -0.26
Pendapatan bersih 3,156 3,513 4,004 6,205 6,996 8,075 7,934 5,687 5,370 4,338 4,183 4,299 3,991 3,954 3,858 4,322 4,654 4,413 4,499 4,459
Perubahan (%) 11.32 13.96 54.99 12.73 15.44 -1.75 -28.32 -5.57 -19.21 -3.59 2.78 -7.16 -0.94 -2.42 12.02 7.70 -5.20 1.96 -0.90
% daripada Hasil 39.76 41.35 43.53 50.11 51.65 50.25 48.06 39.97 39.17 35.64 33.81 33.93 30.47 30.14 29.45 32.04 33.61 31.07 31.94 31.37

Source: Capital IQ

Other Listings
MX:REGN
IT:1REGN €490.80
AT:REGN
GB:0R2M
DE:RGO €489.90
PE:REGN
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista